![Dana Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dana Lee
Företagsledare/Principal på
PHARMACYCLICS, INC.
Profil
Dana Lee is currently Vice President-Drug Safety at Pharmacyclics LLC since 2013.
Formerly, Dr. Lee was Senior Director-Pharmacovigilance Division at Amylin Pharmaceuticals, Inc. in 2011 and Vice President-Medical Affairs at Mast Therapeutics, Inc. in 2012.
Dr. Lee earned a doctorate from The University of California, San Francisco.
Aktiva positioner av Dana Lee
| Företag | Position | Start |
|---|---|---|
| PHARMACYCLICS, INC. | Företagsledare/Principal | 2013-02-01 |
Tidigare kända positioner av Dana Lee
| Företag | Position | Slut |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Teknisk/Vetenskaplig/F&U Direktör | 2012-01-01 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Företagsledare/Principal | 2011-01-01 |
Dana Lees utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
66
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
